Table 4.
Risk of Cirrhosis-Related Complications According to MELD3.0 within the Enrollment of the First 3 Months
| MELD3.0 | p-value | |||
|---|---|---|---|---|
| <10 (n=628) | 10 to <20 (n=1,694) | ≥ 20 (n=992) | ||
| Cirrhosis-related complication, No. (%) | 98 (15.6) | 449 (26.5) | 323 (32.6) | <0.001 |
| New onset or uncontrolled ascites | 75 (11.9) | 346 (20.4) | 155 (25.9) | <0.001 |
| Gastroesophageal varix bleeding | 27 (4.3) | 102 (6.0) | 41 (4.1) | 0.058 |
| Hepatorenal syndrome | 0 (0.0) | 2 (0.1) | 18 (1.8) | <0.001 |
| Hepatic encephalopathy | 3 (0.5) | 45 (2.7) | 58 (5.9) | <0.001 |
MELD3.0, Model for End-Stage Liver Disease 3.0.